Search hospitals
>
Missouri
>
Saint Joseph
Heartland Regional Medical Center
Claim this profile
Saint Joseph, Missouri 64506
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
336 reported clinical trials
2 medical researchers
Summary
Heartland Regional Medical Center is a medical facility located in Saint Joseph, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Heartland Regional Medical Center is involved with conducting 336 clinical trials across 465 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Rony Abou-Jawde, MD.
Area of expertise
Breast Cancer
Heartland Regional Medical Center has run 60 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Heartland Regional Medical Center has run 49 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Jay W Carlson
Mercy Hospital Saint Louis
7 years of reported clinical research
Rony Abou-Jawde, MD
Mosaic Life Care
6 years of reported clinical research
Clinical Trials running at Heartland Regional Medical Center
Breast Cancer
Lung Cancer
Bladder Cancer
Ovarian Cancer
Breast cancer
Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Esophageal cancer
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Mindfulness Approaches
for Living After Breast Cancer
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.
Recruiting
2 awards
Phase 3
5 criteria
HER2-Targeted Therapy
for Breast Cancer
This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherapy with trastuzumab. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer cells. When trastuzumab or pertuzumab attach to HER2, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving 6 months of HER2-targeted therapy may work better than giving 12 months for the treatment of HER2+ breast cancer in patients that had a pCR after neoadjuvant chemotherapy with trastuzumab.
Recruiting
2 awards
Phase 3
5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Heartland Regional Medical Center?
Heartland Regional Medical Center is a medical facility located in Saint Joseph, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Heartland Regional Medical Center is involved with conducting 336 clinical trials across 465 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Rony Abou-Jawde, MD.
Where is Heartland Regional Medical Center located?
**Heartland Regional Medical Center** Location: 5325 Faraon St, St Joseph, MO 64506 Easily accessible by car or public transportation, Heartland Regional Medical Center is conveniently located near the intersection of Faraon St and S 53rd St in Saint Joseph, MO.
Who should I call to ask about financial aid or insurance network?
**Heartland Regional Medical Center Financial Assistance:** - For financial assistance, contact the Financial Assistance team at (844) 652-0603. Assistance is available for low-income individuals and families, including no-interest payment plans. - To apply, download and complete the application in black ink and mail it with proof of income and necessary documents to: 3333 W DeYoung St, Anna, IL 62906. Processing takes 10-14 days, possibly longer if additional information is needed. **Billing & Insurance Inquiries:** - For questions about your bill or payment options, call the Billing & Insurance department at 833-277-8084. **General Inquiries:** - For other questions, contact Heartland Regional Medical Center at (618) 998-7000 or visit the Contact Us page on their website.
What insurance does Heartland Regional Medical Center accept?
Heartland Regional Medical Center accepts a wide range of insurance plans, such as Medicare Advantage, Medicare/Medicaid (MMAI), Managed Medicaid, Commercial and Employer Sponsored, and Medicaid. They provide financial assistance for low-income individuals and families, alongside no-interest payment plans. For uninsured patients, the hospital offers prepayment options or alternative payment arrangements, and assists with Medicaid applications and eligibility verification during hospitalization.
What awards or recognition has Heartland Regional Medical Center received?
Heartland Regional Medical Center, located in Saint Joseph, Missouri, is a recipient of the prestigious Malcolm Baldrige National Award for Quality in 2009, highlighting its dedication to quality and performance excellence. The hospital plays a crucial role in enhancing economic vitality and the health of the region. Its accountable care organization, Heartland Regional Medical Center ACO, has successfully reduced spending and improved health outcomes for Medicare beneficiaries.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.